Ken Griffin Ark Genomic Revolution ETF (De Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Citadel Advisors LLC holds 666,200 shares of ARKG stock, worth $14.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
666,200
Previous 750,000
11.17%
Holding current value
$14.6 Million
Previous $17.7 Million
21.7%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding ARKG
# of Institutions
278Shares Held
20.9MCall Options Held
4.66MPut Options Held
3.85M-
Jpmorgan Chase & CO New York, NY3.43MShares$75.1 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY3.29MShares$71.9 Million0.01% of portfolio
-
Citigroup Inc2.56MShares$56 Million0.03% of portfolio
-
Morgan Stanley New York, NY2.37MShares$51.7 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.2MShares$26.4 Million0.0% of portfolio